Suppr超能文献

与多发性硬化症相关的环境因素的信号通路和治疗前景。

Signaling pathways and therapeutic perspectives related to environmental factors associated with multiple sclerosis.

机构信息

Departments of Immunology, Herbert Wertheim College of Medicine, Florida International University, Miami, Florida.

Human and Molecular Genetics, Herbert Wertheim College of Medicine, Florida International University, Miami, Florida.

出版信息

J Neurosci Res. 2018 Dec;96(12):1831-1846. doi: 10.1002/jnr.24322. Epub 2018 Sep 11.

Abstract

Multiple sclerosis (MS) is an immune-mediated demyelinating disorder of unknown etiology. Both genetic-susceptibility and environment exposures, including vitamin D deficiency, Epstein-Barr viral and Herpesvirus (HHV-6) infections are strongly implicated in the activation of T cells and MS-pathogenesis. Despite precise knowledge of how these factors could be operating alone or in combination to facilitate and aggravate the disease progression, it is clear that prolonged induction of inflammatory molecules and recruitment of other immune cells by the activated T cells results in demyelination and axonal damage. It is imperative to understand the risk factors associated with MS progression and how these factors contribute to disease pathology. Understanding of the underlying mechanisms of what factors triggers activation of T cells to attack myelin antigen are important to strategize therapeutics and therapies against MS. Current review provides a detailed literature to understand the role of both pathogenic and non-pathogenic factors on the impact of MS.

摘要

多发性硬化症(MS)是一种病因不明的免疫介导性脱髓鞘疾病。遗传易感性和环境暴露因素,包括维生素 D 缺乏、EB 病毒和疱疹病毒(HHV-6)感染,强烈提示 T 细胞的激活和 MS 发病机制。尽管确切地了解这些因素如何单独或联合作用以促进和加重疾病进展,但很明显,激活的 T 细胞长时间诱导炎症分子的产生并募集其他免疫细胞,导致脱髓鞘和轴索损伤。了解与 MS 进展相关的危险因素以及这些因素如何导致疾病病理变化至关重要。了解是什么因素触发 T 细胞攻击髓鞘抗原的激活的潜在机制对于制定针对 MS 的治疗策略和疗法非常重要。本综述提供了详细的文献资料,以了解致病性和非致病性因素对 MS 的影响。

相似文献

1
Signaling pathways and therapeutic perspectives related to environmental factors associated with multiple sclerosis.
J Neurosci Res. 2018 Dec;96(12):1831-1846. doi: 10.1002/jnr.24322. Epub 2018 Sep 11.
2
Multiple sclerosis: risk factors and their interactions.
CNS Neurol Disord Drug Targets. 2012 Aug;11(5):545-55. doi: 10.2174/187152712801661266.
3
Multiple sclerosis: immune mechanism and update on current therapies.
Ann Neurol. 1995 May;37 Suppl 1:S87-101. doi: 10.1002/ana.410370710.
5
Inflammation, demyelination, neurodegeneration and neuroprotection in the pathogenesis of multiple sclerosis.
J Neuroimmunol. 2007 Mar;184(1-2):37-44. doi: 10.1016/j.jneuroim.2006.11.015. Epub 2006 Dec 28.
6
7
Molecular Genetic and Epigenetic Basis of Multiple Sclerosis.
Adv Exp Med Biol. 2017;958:65-90. doi: 10.1007/978-3-319-47861-6_6.
8
Novel therapeutic targets for axonal degeneration in multiple sclerosis.
J Neuropathol Exp Neurol. 2010 Apr;69(4):323-34. doi: 10.1097/NEN.0b013e3181d60ddb.
9
Environmental factors in multiple sclerosis: Epstein-Barr virus, vitamin D, and cigarette smoking.
Mt Sinai J Med. 2011 Mar-Apr;78(2):221-30. doi: 10.1002/msj.20240.
10
Advances in the immunopathogenesis of multiple sclerosis.
Curr Opin Neurol. 2015 Jun;28(3):206-19. doi: 10.1097/WCO.0000000000000205.

引用本文的文献

1
Vitamin D in Multiple Sclerosis-Lessons From Animal Studies.
Front Neurol. 2021 Oct 20;12:757795. doi: 10.3389/fneur.2021.757795. eCollection 2021.
2
Vitamin D and Genetic Susceptibility to Multiple Sclerosis.
Biochem Genet. 2021 Feb;59(1):1-30. doi: 10.1007/s10528-020-10010-1. Epub 2020 Nov 7.

本文引用的文献

1
Interleukin-2 shapes the cytotoxic T cell proteome and immune environment-sensing programs.
Sci Signal. 2018 Apr 17;11(526):eaap8112. doi: 10.1126/scisignal.aap8112.
3
Gut bacteria from multiple sclerosis patients modulate human T cells and exacerbate symptoms in mouse models.
Proc Natl Acad Sci U S A. 2017 Oct 3;114(40):10713-10718. doi: 10.1073/pnas.1711235114. Epub 2017 Sep 11.
5
The MHC locus and genetic susceptibility to autoimmune and infectious diseases.
Genome Biol. 2017 Apr 27;18(1):76. doi: 10.1186/s13059-017-1207-1.
6
Multiple Sclerosis: Pathogenesis, Symptoms, Diagnoses and Cell-Based Therapy.
Cell J. 2017 Apr-Jun;19(1):1-10. doi: 10.22074/cellj.2016.4867. Epub 2016 Dec 21.
7
Monoclonal antibodies in the treatment of multiple sclerosis: emergence of B-cell-targeted therapies.
Br J Pharmacol. 2017 Jul;174(13):1895-1907. doi: 10.1111/bph.13780. Epub 2017 Apr 26.
8
The gut microbiome and microbial translocation in multiple sclerosis.
Clin Immunol. 2017 Oct;183:213-224. doi: 10.1016/j.clim.2017.03.001. Epub 2017 Mar 9.
9
B cell treatments for multiple sclerosis.
J Neurol. 2017 Apr;264(4):814-816. doi: 10.1007/s00415-017-8442-y.
10
Biopsy-proven case of Epstein-Barr virus (EBV)-associated vasculitis of the central nervous system.
Neuropathology. 2017 Jun;37(3):259-264. doi: 10.1111/neup.12356. Epub 2016 Dec 22.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验